Markus Oliver Henke

Markus Oliver Henke

Auto-generated profile, based on publicly available information

Markus Oliver Henke

Department of Pulmonary Medicine, Philipps-Universität Marburg, Marburg, Germany

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
MSMasaharu Shinkai
Masaharu Shinkai
MHMarkus O. Henke
Markus O. Henke
BRBruce K. Rubin
Bruce K. Rubin

1 March 2007 in Paediatric Respiratory Reviews
Verified
Journal Article
Closed access
MHMarkus O. Henke
Markus O. Henke
FRFelix Ratjen
Felix Ratjen

1 July 2004 in American Journal of Respiratory Cell and Molecular Biology
Verified
Journal Article
Closed access
MHMarkus O. Henke
Markus O. Henke
ARArmin Renner
Armin Renner
RHRudolf M. Huber
Rudolf M. Huber
MSMichael C. Seeds
Michael C. Seeds
BRBruce K. Rubin
Bruce K. Rubin
Cystic fibrosis (CF) is characterized by progressive airway obstruction. Although it has been postulated that this is due in part to mucus hypersecretion, there are no published data showing an increase in the gel-forming mucins MUC5AC or MUC5B in CF secretions. We used confocal microscopy to assess the amount of mucin-like glycoprotein and DNA in CF sputum and found more mucin in bronchitis sputum and a much greater amount of DNA in CF sputum. We then used antibodies to MUC5AC and MUC5B with Western gels and dot-blot to quantify mucin in sputum from 12 patients with CF and 11 subjects without lung disease. There was a 70% decrease in MUC5B and a 93% decrease in MUC5AC in CF sputum (P < 0.005 for both). We conclude that the vol/vol concentration of MUC5AC and MUC5B are decreased in the CF airways relative to normal mucus. This may be due to a relative increase in other components of sputum in the CF airway or to a primary defect in mucin secretion in CF.

15 April 2007 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
MHMarkus O. Henke
Markus O. Henke
GJGerrit John
Gerrit John
MGMichele Germann
Michele Germann
HLHermann Lindemann
Hermann Lindemann
BRBruce K. Rubin
Bruce K. Rubin
Rationale: Cystic fibrosis (CF) is believed to be associated with mucus hypersecretion; thus, the principal airway gel-forming mucins, MUC5AC and MUC5B, are also expected to be increased relative to non-CF secretions. However, we have shown that these mucins are decreased during stable CF disease. Objectives: In this study, we determine if these mucins increase during a pulmonary exacerbation of CF. Methods: Expectorated sputum was collected from 11 adults with CF during stable disease and then during a pulmonary exacerbation and from 12 healthy control subjects. MUC5AC and MUC5B proteins were measured by Western blot. DNA content was measured using microfluorimetry. Results: MUC5AC protein increased by 908% and MUC5B by 59% (p < 0.05 for both) during an exacerbation compared with periods of stable disease. During stable disease, the vol/vol quantity of MUC5AC protein was 89% less than normal mucus, and the mucin-associated sugars, measured using a lectin binding assay, were 46% less compared with normal mucus. The concentration of DNA in CF sputum did not increase during an exacerbation. Conclusions: During a CF exacerbation, concentration of secreted mucin increased to the amount found in mucus from normal subjects, suggesting that the capacity to secrete mucin in response to an infection or inflammatory stimulus is preserved in CF airways. This might help to protect the airway from injury.

1 January 2006 in Chest
Verified
Journal Article
Closed access
ABAndrew Bush
Andrew Bush
DPDonald Payne
Donald Payne
SPSarah Pike
Sarah Pike
GJGavin Jenkins
Gavin Jenkins
MHMarkus O. Henke
Markus O. Henke
BRBruce K. Rubin
Bruce K. Rubin